- Report
- September 2021
- 111 Pages
Global
From €3974EUR$4,500USD£3,476GBP
- Report
- April 2024
- 176 Pages
Global
From €3974EUR$4,500USD£3,476GBP
- Report
- August 2022
- 119 Pages
Global
From €3974EUR$4,500USD£3,476GBP
- Report
- December 2024
- 205 Pages
Global
From €2208EUR$2,500USD£1,931GBP
- Report
- June 2025
- 200 Pages
India
From €2199EUR$2,490USD£1,923GBP
- Report
- November 2024
- 100 Pages
Global
From €2199EUR$2,490USD£1,923GBP
- Report
- August 2023
- 250 Pages
Global
From €2199EUR$2,490USD£1,923GBP
- Report
- January 2023
- 50 Pages
China
From €2649EUR$3,000USD£2,317GBP
- Report
- July 2022
- 40 Pages
China
From €2826EUR$3,200USD£2,472GBP
- Report
- July 2021
- 50 Pages
China
From €2296EUR$2,600USD£2,008GBP
- Report
- July 2021
- 50 Pages
China
From €2296EUR$2,600USD£2,008GBP
- Report
- May 2021
- 50 Pages
China
From €2296EUR$2,600USD£2,008GBP
- Report
- May 2021
- 50 Pages
China
From €2296EUR$2,600USD£2,008GBP
- Report
- April 2021
China
From €2296EUR$2,600USD£2,008GBP
- Report
- April 2021
China
From €2296EUR$2,600USD£2,008GBP
- Report
- April 2021
- 40 Pages
China
From €2296EUR$2,600USD£2,008GBP
- Report
- April 2021
- 50 Pages
China
From €2296EUR$2,600USD£2,008GBP
- Report
- August 2019
- 30 Pages
China
From €1943EUR$2,200USD£1,699GBP
- Report
- August 2019
- 30 Pages
China
From €1943EUR$2,200USD£1,699GBP
- Report
- July 2018
- 30 Pages
China
From €1943EUR$2,200USD£1,699GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more